Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AGL | -14.48% | $989.35M | -58.43% | 0.00% |
RDNT | -12.02% | $4.15B | -2.42% | 0.00% |
GALT | -10.94% | $132.28M | -11.81% | 0.00% |
BTCT | -10.83% | $25.33M | +62.02% | 0.00% |
NATR | -10.36% | $290.80M | +10.45% | 0.00% |
STRL | -10.01% | $6.90B | +104.38% | 0.00% |
COIN | -9.36% | $90.37B | +61.30% | 0.00% |
ZVIA | -9.28% | $199.52M | +316.55% | 0.00% |
AIFU | -9.13% | $15.34M | +65.63% | 0.00% |
BTBT | -8.93% | $1.06B | +6.55% | 0.00% |
HNRG | -8.74% | $701.37M | +127.30% | 0.00% |
TLN | -8.53% | $12.63B | +121.95% | 0.00% |
ORN | -8.42% | $344.91M | +5.31% | 0.00% |
CCRN | -7.96% | $418.97M | -3.84% | 0.00% |
MSTR | -7.88% | $108.52B | +204.92% | 0.00% |
CRMD | -7.65% | $839.56M | +162.33% | 0.00% |
CANG | -7.63% | $358.67M | +183.51% | 0.00% |
FARO | -5.91% | $847.82M | +166.97% | 0.00% |
GIFI | -5.91% | $113.57M | +13.64% | 0.00% |
IREN | -5.90% | $4.07B | +31.75% | 0.00% |
Yahoo
AbbVie Inc. (NYSE:ABBV) is one of the best high growth stocks. On June 30, Morgan Stanley maintained an Overweight rating and a $250 price target on AbbVie, in light of the company’s recent acquisition announcement. Recently, AbbVie announced its intention to acquire Capstan Therapeutics, a clinical-stage biotechnology firm specializing in in-vivo cell engineering through RNA […]
Yahoo
Investors are digesting Trump's stiff tariffs on imports from more than a dozen countries and delayed the return of sweeping April levies.
Yahoo
Market Domination host Josh Lipton tracks key movers and headlines in this Market Minute. Pharma stocks such as Pfizer (PFE), Amgen (AMGN), and AbbVie (ABBV) are in focus after President Trump warned of tariffs up to 200%, though he hinted at a grace period for companies shifting production to the US. Uber (UBER) briefly hit another intraday record. Meanwhile, Wendy’s (WEN) CEO Kirk Tanner will exit the company to lead Hershey (HSY), with CFO Ken Cook stepping in as interim chief of the fast food chain. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
Yahoo
The nocturia market, valued at USD 3.30 Billion in 2024, is projected to reach USD 7.32 Billion by 2034, growing at an 8.30% CAGR. Factors driving growth include rising nocturia prevalence, especially among the aging population, technological advancements, and innovative treatments. Key players include Urigen Pharmaceuticals, Glenmark, and AbbVie. Nocturia Market Nocturia Market Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Nocturia Market Report and Forecast 2025-2034" has been added to Resear
Yahoo
ABBV leans on Skyrizi and Rinvoq sales strength to offset Humira's decline ahead of its Q2 earnings report.
Yahoo
AbbVie Inc. (NYSE:ABBV) is one of the most undervalued large cap stocks to buy according to analysts. On June 30, AbbVie announced its intention to acquire Capstan Therapeutics in a deal valued at up to $2.1 billion in cash. The acquisition will expand AbbVie’s product pipeline, particularly in experimental treatments for autoimmune diseases. Capstan Therapeutics […]
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CORN | -0.31% | $45.73M | 0.2% |
UTWO | 0.32% | $376.38M | 0.15% |
PALL | 0.38% | $509.81M | 0.6% |
FXC | -0.40% | $93.54M | 0.4% |
IBTH | 0.47% | $1.61B | 0.07% |
ULST | -0.47% | $595.49M | 0.2% |
IBDQ | 0.48% | $2.96B | 0.1% |
TBLL | -0.61% | $2.12B | 0.08% |
BTAL | -0.70% | $312.42M | 1.43% |
FXE | 0.77% | $585.58M | 0.4% |
BLOK | 0.83% | $1.11B | 0.76% |
URNM | 1.13% | $1.73B | 0.75% |
VGSH | 1.14% | $22.64B | 0.03% |
SPTS | -1.27% | $5.77B | 0.03% |
ASHR | 1.28% | $1.92B | 0.65% |
FXY | 1.30% | $812.67M | 0.4% |
CNYA | 1.67% | $197.07M | 0.6% |
SGOV | 1.70% | $50.43B | 0.09% |
JMST | 1.79% | $4.08B | 0.18% |
CANE | 1.84% | $11.26M | 0.29% |
Current Value
$188.501 Year Return
Current Value
$188.501 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -27.77% | $185.99M | 0.85% |
TAIL | -24.82% | $95.09M | 0.59% |
CLIP | -19.52% | $1.54B | 0.07% |
IVOL | -14.89% | $342.02M | 1.02% |
TESL | -9.71% | $33.16M | 1.2% |
DEFI | -9.55% | $14.93M | 0.94% |
TPMN | -9.43% | $30.94M | 0.65% |
CONY | -9.05% | $1.38B | 1.22% |
BTC | -8.84% | $4.85B | 0.15% |
FTSD | -8.83% | $233.04M | 0.25% |
BRRR | -8.05% | $642.72M | 0.25% |
IBIT | -7.92% | $76.74B | 0.25% |
HODL | -7.91% | $1.73B | 0.25% |
BITO | -7.90% | $2.62B | 0.95% |
FBTC | -7.89% | $22.35B | 0.25% |
GBTC | -7.80% | $20.24B | 1.5% |
ARKB | -7.78% | $5.30B | 0.21% |
BTCO | -7.75% | $579.67M | 0.39% |
BITB | -7.72% | $4.40B | 0.2% |
EZBC | -7.57% | $575.48M | 0.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FDL | 62.88% | $5.59B | 0.43% |
XLV | 60.43% | $34.49B | 0.09% |
PPH | 60.41% | $589.08M | 0.36% |
HDV | 60.20% | $11.20B | 0.08% |
IYH | 59.63% | $2.74B | 0.39% |
VHT | 58.82% | $15.43B | 0.09% |
FHLC | 58.78% | $2.45B | 0.084% |
IXJ | 58.10% | $3.76B | 0.41% |
SPHD | 56.69% | $3.23B | 0.3% |
DHS | 56.40% | $1.26B | 0.38% |
BBH | 54.37% | $340.09M | 0.35% |
RSPH | 54.02% | $726.61M | 0.4% |
SCHD | 53.30% | $71.26B | 0.06% |
IHE | 52.32% | $559.80M | 0.39% |
SPYD | 52.30% | $6.99B | 0.07% |
DIV | 50.73% | $658.97M | 0.45% |
CDC | 50.62% | $750.81M | 0.42% |
LVHD | 50.39% | $571.73M | 0.27% |
IBB | 50.37% | $5.44B | 0.45% |
SDOG | 50.24% | $1.22B | 0.36% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PFE | 56.17% | $145.66B | -7.58% | 6.64% |
MTD | 52.06% | $25.08B | -7.76% | 0.00% |
AMGN | 50.29% | $159.70B | -5.99% | 3.11% |
RYN | 48.66% | $3.60B | -16.65% | 4.81% |
TMO | 46.93% | $160.88B | -19.87% | 0.39% |
WY | 46.84% | $18.98B | -5.08% | 3.13% |
TECH | 45.94% | $8.26B | -26.10% | 0.61% |
NVS | 45.70% | $230.90B | +12.43% | 3.27% |
ES | 45.04% | $23.72B | +11.62% | 4.54% |
JNJ | 44.88% | $374.84B | +5.94% | 3.23% |
MKC | 44.22% | $19.56B | +4.04% | 3.01% |
PCH | 44.06% | $3.17B | +7.14% | 4.47% |
NSA | 43.91% | $2.46B | -19.84% | 7.03% |
MRK | 43.78% | $204.32B | -35.44% | 3.88% |
SPNS | 43.36% | $1.65B | -14.78% | 1.96% |
ARE | 43.09% | $13.32B | -33.63% | 6.80% |
DOC | 42.86% | $12.65B | -7.28% | 6.63% |
GILD | 42.71% | $138.15B | +63.90% | 2.79% |
RITM | 42.31% | $6.18B | +9.08% | 8.55% |
CPT | 42.17% | $12.11B | +4.91% | 3.66% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FUBO | -0.01% | $1.23B | +191.13% | 0.00% |
POWL | 0.03% | $2.61B | +57.63% | 0.48% |
JOBY | -0.03% | $9.02B | +122.90% | 0.00% |
LITB | 0.07% | $23.17M | -74.54% | 0.00% |
RLX | -0.10% | $2.07B | +25.27% | 0.44% |
SMLR | -0.11% | $465.13M | +25.03% | 0.00% |
SSYS | 0.12% | $973.20M | +35.60% | 0.00% |
WBA | 0.12% | $9.97B | +6.77% | 4.34% |
LFWD | 0.15% | $11.99M | -79.88% | 0.00% |
PLCE | -0.16% | $110.84M | -44.38% | 0.00% |
AFRM | -0.20% | $21.85B | +138.82% | 0.00% |
DAKT | -0.22% | $822.16M | +22.46% | 0.00% |
SYPR | 0.23% | $48.26M | +12.26% | 0.00% |
APRE | 0.26% | $9.96M | -52.13% | 0.00% |
AAON | -0.26% | $6.13B | -10.29% | 0.47% |
UPWK | -0.28% | $1.78B | +18.63% | 0.00% |
AMTX | 0.30% | $193.24M | +0.87% | 0.00% |
ACEL | 0.31% | $1.03B | +23.33% | 0.00% |
RIOT | 0.31% | $4.13B | +26.59% | 0.00% |
WRAP | -0.33% | $76.37M | -12.21% | 0.00% |
Double maintains 15 strategies that include ABBV - AbbVie, Inc.